Zalunfiban dihydrochloride

Additional information:
Zalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist (IC50=45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).|Product information|Molecular Weight: 459.35|Formula: C16H20Cl2N8O2S|Chemical Name: 2-amino-N-(5-(5-oxo-7-(piperazin-1-yl)-5H-[1, 3, 4]thiadiazolo[3, 2-a]pyrimidin-2-yl)pyridin-3-yl)acetamide dihydrochloride|Smiles: Cl.Cl.NCC(=O)NC1=CC(=CN=C1)C1=NN2C(=NC(=CC2=O)N2CCNCC2)S1|InChiKey: GVDRCFLSNUIMCT-UHFFFAOYSA-N|InChi: InChI=1S/C16H18N8O2S.2ClH/c17-7-13(25)20-11-5-10(8-19-9-11)15-22-24-14(26)6-12(21-16(24)27-15)23-3-1-18-2-4-23;;/h5-6,8-9,18H,1-4,7,17H2,(H,20,25);2*1H|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.Moxetumomab Cancer |Shelf Life: ≥12 months if stored properly.Camidanlumab MedChemExpress |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:33249960 |Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Zalunfiban dihydrochloride (1~3.86 mg/kg; s.c.; 24 hours) makes platelet aggregation performed. Zalunfiban dihydrochloride (1~3.86 mg/kg; i.m.; 4.5 hours) leads to the onset of high-grade inhibition of platelet aggregation within 15–30 minutes that lasts from ~2 to >4.5 hours in a dose dependent manner.|Products are for research use only. Not for human use.|